Life Sciences
This separately managed account program is a joint venture between ELCO Management Co., LLC (ELCO) and Phenomic Capital. It is a proprietary investment strategy in which Phenomic Capital is a consultant and ELCO is the manager.
ELCO leverages the significant scientific and investment success of Mark Charest, PhD, of Phenomic Capital, a global biotech/healthcare consultant. ELCO’s Life Sciences separately managed account program plans to invest in small, mid, and large cap biotech, pharmaceutical, healthcare and life science companies addressing areas of high unmet medical need.
The objective is to generate above average long-term capital appreciation. The combination of Phenomic Capital’s medical and scientific research, coupled with their investment experience, provides investors a differentiated perspective to investing in this space.